Adar1 Capital Management, LLC Kymera Therapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $539 Billion
- Q1 2025
A detailed history of Adar1 Capital Management, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 10,000 shares of KYMR stock, worth $300,200. This represents 0.05% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$300,200
Previous $402 Million
31.97%
% of portfolio
0.05%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding KYMR
# of Institutions
182Shares Held
66.9MCall Options Held
223KPut Options Held
241K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$201 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$194 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$180 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$180 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$157 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.64B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...